Jump to content

RFX5

From Wikipedia, the free encyclopedia

RFX5
Available structures
PDBOrtholog search:PDBeRCSB
Identifiers
AliasesRFX5,regulatory factor X5
External IDsOMIM:601863;MGI:1858421;HomoloGene:388;GeneCards:RFX5;OMA:RFX5 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000449
NM_001025603

NM_017395
NM_001355705
NM_001355706
NM_001355707
NM_001025601

RefSeq (protein)

NP_059091
NP_001342634
NP_001342635
NP_001342636

Location (UCSC)Chr 1: 151.34 – 151.35 MbChr 3: 94.86 – 94.87 Mb
PubMedsearch[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

DNA-binding protein RFX5is aproteinthat in humans is encoded by theRFX5gene.[5][6]

Function

[edit]

A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the Xbox of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined.[6]

Interactions

[edit]

RFX5 has been shown tointeractwithCIITA.[7][8]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000143390Ensembl,May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000005774Ensembl,May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Villard J, Reith W, Barras E, Gos A, Morris MA, Antonarakis SE, Van den Elsen PJ, Mach B (January 1998). "Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency".Human Mutation.10(6): 430–5.doi:10.1002/(SICI)1098-1004(1997)10:6<430::AID-HUMU3>3.0.CO;2-H.PMID9401005.S2CID41660134.
  6. ^ab"Entrez Gene: RFX5 regulatory factor X, 5 (influences HLA class II expression)".
  7. ^Hake SB, Masternak K, Kammerbauer C, Janzen C, Reith W, Steimle V (Oct 2000)."CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation".Molecular and Cellular Biology.20(20): 7716–25.doi:10.1128/MCB.20.20.7716-7725.2000.PMC86349.PMID11003667.
  8. ^Scholl T, Mahanta SK, Strominger JL (Jun 1997)."Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5".Proceedings of the National Academy of Sciences of the United States of America.94(12): 6330–4.Bibcode:1997PNAS...94.6330S.doi:10.1073/pnas.94.12.6330.PMC21049.PMID9177217.

Further reading

[edit]
[edit]

This article incorporates text from theUnited States National Library of Medicine,which is in thepublic domain.